Lallemand Pharma

News details

Sep
30,
2020

Bacterial Lysates as Immunotherapies for Respiratory Infections:

Sep 30, 2020

Bacterial lysates, prepared from the microorganisms most frequently involved in human
Respiratory Tract Infections (RTIs) have been in the market for several decades, and
at present, several different brands are available in many countries worldwide.